Global pharma major Lupin Limited has received tentative approval from the US Food and Drug Administration for its new drug application for Dolutegravir Lamivudine and...
Generic drugmaker Lupin Ltd announced that it had received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)...
Shares of Lupin rose 2% intraday on March 27 after the drugmaker received preliminary approval from the US Food and Drug Administration (USFDA) for Valbenazine...
On March 21, Pharma major Lupin shares increased 1.6% in the early trade after the company’s alliance partner Caplin Steriles got two final approvals from...
Lupin shares rose in early trading on March 14 after receiving a “no observation” certificate from the US Food and Drug Administration (USFDA). At 9:16...